Pfizer’s 6.7% Yield Looks Scary — but the Dividend Story Is Stronger Than It Seems

0
163

The S&P 500 index (SNPINDEX: ^GSPC) has a tiny yield of 1.1%. The average pharmaceutical company’s yield is 1.7%. Those comparison points make Pfizer‘s (NYSE: PFE) 6.7% dividend yield look shockingly large. If you are a dividend investor, is it worth buying Pfizer, or is the risk of a dividend cut too great? The dividend is probably on stronger ground than you think.

Who sets Pfizer’s dividend policy?

When you boil it all down, the board of directors decides on a company’s dividend policy. It is entirely up to this group. Obviously, they don’t work in a vacuum. The board consults with a company’s CEO and other top executives before making a dividend decision. So, what management says is often a good indication of what the board is thinking.

Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here